The role of SIRT1 expression–activity on progression and prognosis of gliomas can now be investigated more accurately using quantitative imaging of SIRT1 expression–activity in tumor tissue in vivo, in the native microenvironment of individual tumors. The gene discussed is SIRT1; the disease is neoplasm.